Trial
NCT06462144
IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Collaborators
—
Condition
Systemic Lupus Erythematosus (SLE)
Intervention
IMPT-514 CART Cell Injection
Why stopped
The collaborating party has adjusted its R\&D strategy and terminated the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-28